{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T04:19:40Z","timestamp":1743913180342,"version":"3.40.3"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.vaccine.2025.126708","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T10:10:14Z","timestamp":1736763014000},"page":"126708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Examining homology between MPXV and immunogenic VACV-derived peptides"],"prefix":"10.1016","volume":"48","author":[{"given":"Lara I.","family":"Teodoro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna G.","family":"Ovsyannikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1988","series-title":"Smallpox and its eradication","author":"Fenner","key":"10.1016\/j.vaccine.2025.126708_bb0005"},{"issue":"13","key":"10.1016\/j.vaccine.2025.126708_bb0010","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa1407647","article-title":"Human infection with a zoonotic orthopoxvirus in the country of Georgia","volume":"372","author":"Vora","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126708_bb0015","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","article-title":"Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus","volume":"28","author":"Isidro","year":"2022","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126708_bb0020","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3390\/pathogens12091153","article-title":"Monitoring Monkeypox: safeguarding global health through rapid response and global surveillance","volume":"12","author":"Giovanetti","year":"2023","journal-title":"Pathogens"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126708_bb0025","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220415120","article-title":"Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model","volume":"120","author":"Americo","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"author":"World Health Organization","key":"10.1016\/j.vaccine.2025.126708_bb0030"},{"key":"10.1016\/j.vaccine.2025.126708_bb0035","article-title":"Mpox: Virus behind new DRC outbreak is most dangerous strain yet, experts warn","volume":"385","author":"Dyer","year":"2024","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126708_bb0040","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300290","article-title":"Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults","volume":"3","author":"Morino","year":"2024","journal-title":"NEJM Evid"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126708_bb0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ije\/17.3.643","article-title":"The Transmission Potential of Monkeypox Virus in Human Populations","volume":"17","author":"Fine","year":"1988","journal-title":"Int J Epidemiol"},{"author":"Centers for Disease Control and Prevention","key":"10.1016\/j.vaccine.2025.126708_bb0050"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126708_bb0055","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.vaccine.2023.12.066","article-title":"JYNNEOS effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak data","volume":"42","author":"Rosen","year":"2024","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126708_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20042963","article-title":"Safety and efficacy of post-eradication smallpox vaccine as an Mpox vaccine: A systematic review with meta-analysis","volume":"20","author":"Malone","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"19","key":"10.1016\/j.vaccine.2025.126708_bb0065","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jama.2024.20951","article-title":"Decline of Mpox antibody responses after modified vaccinia Ankara-Bavarian Nordic Vaccination","volume":"332","author":"Collier","year":"2024","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126708_bb0070","article-title":"Evaluating the Immunogenicity and Safety of a Smallpox Vaccine to Monkeypox in Healthy Japanese Adults: A Single-Arm Study","volume":"13","author":"Tomita","year":"2023","journal-title":"Life (Basel)"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126708_bb0075","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide vaccine: progress and challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126708_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11071832","article-title":"An updated review on Monkeypox viral disease: emphasis on genomic diversity","volume":"11","author":"Rabaan","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126708_bb0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.vaccine.2009.09.126","article-title":"Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development","volume":"28","author":"Johnson","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126708_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19679-3","article-title":"Evaluating immunogenicity of pathogen-derived T-cell epitopes to design a peptide-based smallpox vaccine","volume":"12","author":"Quach","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126708_bb0095","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.virol.2010.09.013","article-title":"The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins","volume":"408","author":"Kennedy","year":"2010","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126708_bb0100","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/sj.clpt.6100389","article-title":"Mass spectrometry and peptide-based vaccine development","volume":"82","author":"Ovsyannikova","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126708_bb0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.chom.2013.06.006","article-title":"Vaccinia virus F11 promotes viral spread by acting as a PDZ-containing scaffolding protein to bind myosin-9A and inhibit RhoA signaling","volume":"14","author":"Handa","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126708_bb0110","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a010199","article-title":"Poxvirus DNA replication","volume":"5","author":"Moss","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126708_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1515","article-title":"Translational control during poxvirus infection","volume":"10","author":"Meade","year":"2019","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126708_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/v9080215","article-title":"Poxviruses utilize multiple strategies to inhibit apoptosis","volume":"9","author":"Nichols","year":"2017","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126708_bb0125","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/v2051050","article-title":"Surf and turf: mechanism of enhanced virus spread during poxvirus infection","volume":"2","author":"Condit","year":"2010","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126708_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2023.04.015","article-title":"Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox","volume":"31","author":"Adamo","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126708_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2022.11.003","article-title":"Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans","volume":"30","author":"Grifoni","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126708_bb0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide vaccine: progress and challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126708_bb0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1084\/jem.20041912","article-title":"Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines","volume":"201","author":"Tscharke","year":"2005","journal-title":"J Exp Med"},{"issue":"13","key":"10.1016\/j.vaccine.2025.126708_bb0150","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1128\/JVI.78.13.7052-7060.2004","article-title":"Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses","volume":"78","author":"Snyder","year":"2004","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T18:00:32Z","timestamp":1743876032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":30,"alternative-id":["S0264410X25000052"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126708","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining homology between MPXV and immunogenic VACV-derived peptides","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126708"}}